CA2150383A1 - Antacid composition and method of production - Google Patents

Antacid composition and method of production

Info

Publication number
CA2150383A1
CA2150383A1 CA002150383A CA2150383A CA2150383A1 CA 2150383 A1 CA2150383 A1 CA 2150383A1 CA 002150383 A CA002150383 A CA 002150383A CA 2150383 A CA2150383 A CA 2150383A CA 2150383 A1 CA2150383 A1 CA 2150383A1
Authority
CA
Canada
Prior art keywords
particles
antacid
aluminum
antacid composition
particle size
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002150383A
Other languages
English (en)
French (fr)
Inventor
Gary G. Liversidge
Gregory L. Mcintire
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanosystems LLC
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2150383A1 publication Critical patent/CA2150383A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA002150383A 1992-12-11 1993-12-03 Antacid composition and method of production Abandoned CA2150383A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98929692A 1992-12-11 1992-12-11
US989,296 1992-12-11

Publications (1)

Publication Number Publication Date
CA2150383A1 true CA2150383A1 (en) 1994-06-23

Family

ID=25534976

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002150383A Abandoned CA2150383A1 (en) 1992-12-11 1993-12-03 Antacid composition and method of production

Country Status (10)

Country Link
EP (1) EP0673253A1 (ko)
JP (1) JPH08504442A (ko)
KR (1) KR950703982A (ko)
AU (1) AU6390894A (ko)
CA (1) CA2150383A1 (ko)
CZ (1) CZ148695A3 (ko)
FI (1) FI952859A (ko)
NO (1) NO952261D0 (ko)
SK (1) SK76595A3 (ko)
WO (1) WO1994013304A2 (ko)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69413544T2 (de) * 1993-08-24 1999-05-27 Kappa Pharmaceuticals Ltd., Reading Reduzierte absorption von fettsäuren
DE69535669T2 (de) 1994-05-09 2008-12-04 Oxford Biomedica (Uk) Ltd. Retrovirale vektoren mit verminderter rekombinationsrate
US5874112A (en) * 1997-03-31 1999-02-23 Mcneil Ppc-Inc. Translucent antacid suspension
AU2002951438A0 (en) * 2002-09-17 2002-10-03 Nauveau Technology Investments Ltd Methods and compositions for treatment of excess stomach acid in mammals
RU2013148719A (ru) * 2013-10-31 2015-05-10 Геннадий Гильфанович Галимов Композиция на основе гидроксоалюмината хлорида магния, содержащая гидроксид магния, в качестве терапевтического препарата
WO2016104367A1 (ja) * 2014-12-22 2016-06-30 株式会社Ｌｔｔバイオファーマ 機能性ディスペプシア治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3843778A (en) * 1970-04-28 1974-10-22 Rorer Inc William H Antacids
US4271142A (en) * 1979-06-18 1981-06-02 Life Savers, Inc. Portable liquid antacids
FR2512344A1 (fr) * 1981-09-08 1983-03-11 Af Aplicaciones Far Lab Procede de fabrication d'une suspension stable d'hydroxyde d'alumine et/ou d'hydroxyde de magnesie comme agent actif des antacida

Also Published As

Publication number Publication date
WO1994013304A3 (en) 1994-09-01
EP0673253A1 (en) 1995-09-27
JPH08504442A (ja) 1996-05-14
FI952859A0 (fi) 1995-06-09
CZ148695A3 (en) 1995-12-13
KR950703982A (ko) 1995-11-17
NO952261L (no) 1995-06-08
AU6390894A (en) 1994-07-04
WO1994013304A2 (en) 1994-06-23
SK76595A3 (en) 1997-01-08
FI952859A (fi) 1995-06-09
NO952261D0 (no) 1995-06-08

Similar Documents

Publication Publication Date Title
EP0644755B1 (en) Surface modified nsaid nanoparticles
EP0812187B1 (en) Solid nanoparticulate pharmaceutical composition
EP0602702B1 (en) The use of tyloxapol as a nanoparticle stabilizer and dispersant
RU2186562C2 (ru) Композиции, представляющие собой микрочастицы веществ, нерастворимых в воде, и способ их изготовления
US5336507A (en) Use of charged phospholipids to reduce nanoparticle aggregation
CA2212779C (en) Compositions comprising nanoparticles of nsaid
US5622938A (en) Sugar base surfactant for nanocrystals
US7687071B1 (en) Nanoparticulate core shell systems and the use thereof in pharmaceutical and cosmetic preparation
JPH06227968A (ja) ナノ粒子を含む組成物及びその製造方法
EP1079808B1 (en) Thermoprotected microparticle compositions and process for terminal steam sterilization thereof
SK68193A3 (en) Surface modified anticancer nanoparticles
HU228849B1 (hu) Fenofibrát-tartalmú, hidrofil polimer oldatával készült szuszpenzió
TW201513896A (zh) 醋酸阿比特龍配方
HU221586B (hu) Módosított felületű hatóanyag-nanorészecskéket tartalmazó diszperzió, eljárás annak előállítására és az ezt tartalmazó gyógyszerkészítmények
EP2925296B1 (en) Compositions for the treatment of rosacea
CA2150383A1 (en) Antacid composition and method of production
HUT72052A (en) Antacid compositions and methods of production
AU743917B2 (en) Compositions comprising microparticles of water-insoluble substances
MXPA99001691A (es) Composiciones que comprenden microparticulas de sustancias insolubles en agua, y metodo para su preparacion

Legal Events

Date Code Title Description
FZDE Discontinued